3963 Maple Avenue
Suite 350
Dallas, TX 75219
United States
972 499 3350
https://instilbio.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 49
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Bronson Crouch | Chairman & CEO | 672,37k | N/A | 1973 |
Dr. Sandeep Laumas M.D. | CFO & Chief Business Officer | 489,14k | N/A | 1969 |
Dr. Mark E. Dudley Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
Dr. Robert Hawkins MBBS, Ph.D. | Head of Research & Development | 218,72k | N/A | N/A |
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Instil Bio, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.